Possibly the most undervalued stock on the TSX!

2021년 11월 15일- 19M mkt cap / 11M float
- 28.4M cash eq.
- 17.1M Q3 revenue / 7M adjusted EBITDA
- Options at $3.27
- Warrants at $3.53
- Enterprise value (as of Sep 30, 2021): 103.8M!!
- Canadian Commercial business is focused on Pain, Neurology, Allergy, And Dermatology therapeutics.
- 17 Global Distribution Partners across 31 Countries.
- Over 100 global patents and patent applications
- 20+ products, 7 proprietary products, ~ 100 employees